COVID-19 Therapeutics I: Efficacy of COR-101 for the treatment of hospitalised patients with moderate to severe COVID-19 disease (CORAT-1)
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:0 publications
Grant number: 16LW0016
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$8,966,211.98Funder
Federal Ministry of Research, Technology and Space (BMFTR)Research Location
GermanyLead Research Institution
CORAT Therapeutics GmbHResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified